Source:http://linkedlifedata.com/resource/pubmed/id/15243941
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2004-7-9
|
pubmed:abstractText |
T cells are required for normal host defense against fungal infection, and individuals with T cell-deficiency syndromes are highly susceptible to fungal pathogens. Interleukin (IL)-17A is a proinflammatory cytokine that interconnects myeloid and lymphoid host defense. The role of murine (m) IL-17A/mIL-17A receptor (R) interactions was evaluated in a murine model of systemic candidiasis. In response to systemic challenge with Candida albicans, expression of mIL-17A was induced, and IL-17AR knockout (IL-17AR(-/-)) mice had dose-dependent, substantially reduced survival. Fungal burden in the kidneys of IL-17AR(-/-) mice was dramatically increased (25-fold at 96 h). In IL-17AR(-/-) mice, both mobilization of peripheral neutrophils and their influx to infected organs were significantly impaired and delayed. In vivo expression of mIL-17A protected normal mice from a lethal dose of C. albicans (100% at day 7 and 65% at day 42). The data suggest that the mIL-17A/mIL-17AR system is required for normal fungal host defense in vivo. IL-17A could have potential as a therapeutic cytokine for systemic C. albicans infections in immunocompromised patients with cancer or advanced acquired immunodeficiency syndrome.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/IL17RA protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Il17r protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-17,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-17,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0022-1899
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
190
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
624-31
|
pubmed:dateRevised |
2008-5-6
|
pubmed:meshHeading |
pubmed-meshheading:15243941-Animals,
pubmed-meshheading:15243941-Candida albicans,
pubmed-meshheading:15243941-Candidiasis,
pubmed-meshheading:15243941-Disease Models, Animal,
pubmed-meshheading:15243941-Humans,
pubmed-meshheading:15243941-Interleukin-17,
pubmed-meshheading:15243941-Kidney,
pubmed-meshheading:15243941-Mice,
pubmed-meshheading:15243941-Mice, Inbred C57BL,
pubmed-meshheading:15243941-Mice, Knockout,
pubmed-meshheading:15243941-Receptors, Interleukin,
pubmed-meshheading:15243941-Receptors, Interleukin-17,
pubmed-meshheading:15243941-Recombinant Proteins
|
pubmed:year |
2004
|
pubmed:articleTitle |
Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice.
|
pubmed:affiliation |
Gene Therapy Program, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70122, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|